Description
TechNavio's analysts forecast the
Global Parkinson's Disease market to grow at a CAGR of 1.67 percent over the
period 2012-2016. One of the key factors contributing to this market growth is
the rise in the aging population. The Global Parkinson’s Disease market has
also been witnessing the transition toward using drugs that have new mechanisms
of action. However, weak pipeline landscape could pose a challenge to the
growth of this market.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/global-parkinsons-disease-market-2012-2016
TechNavio's report, the Global
Parkinson's Disease Market 2012-2016, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the market
in the Americas, and the EMEA and APAC regions; it also covers the Global
Parkinson's Disease market landscape and its growth prospects in the coming
years. The report also includes a discussion of the key vendors operating in
this market.
The key vendors dominating this
space include GlaxoSmithKline plc, Novartis AG, Orion Corp., and Teva
Pharmaceuticals Industries Ltd.
The other vendors mentioned in the
report are AbbVie Inc., Acadia Pharmaceuticals Inc., Avicena Group Inc.,
BoehringerIngelheim GmbH, Impax Laboratories Inc., Lundbeck A/S, Newron
Pharmaceuticals SpA, Solvay Pharmaceuticals Inc., and Valeant International
SRL.
TABLE OF CONTENT
1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Market Research Methodology
Market Research Process
Research Design
Research Methodology
5. Scope of the Report
Market Overview
Product Offerings
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment